The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency.
Prerna AroraCheila RochaAmy KempfInga NehlmeierLuise GraichenMartin S WinklerMartin LierSebastian R SchulzHans-Martin JäckAnne CossmannMetodi V StankovGeorg Martin Norbert BehrensStefan H PöhlmannMarkus HoffmannPublished in: Cellular & molecular immunology (2021)